Although amphetamine (AMPH)-induced appetite suppression has been attributed to its inhibitory action on neuropeptide Y (NPY), an appetite neurotransmitter abundant in the brain, molecular mechanisms underlying this effect are not well known. This manuscript examined the possible role of protein kinase A (PKA) and cAMP response element binding protein (CREB) signaling in this anorectic effect, and the results showed that both PKA and CREB mRNA levels in hypothalamus were increased following AMPH treatment, which were relevant to a reduction of NPY mRNA level. To determine if PKA or CREB was involved in the anorectic response, the intracerebroventricular infusions of antisense oligonucleotide (or missense control) were performed at 60 min before daily AMPH treatment in conscious rats, and results showed that either PKA or CREB knock down could block AMPH-induced anorexia as well as restore NPY mRNA level, indicating the respective involvement of PKA and CREB signaling in the regulation of NPY gene expression. It is suggested that hypothalamic PKA and CREB signaling may involve the central regulation of AMPH-mediated feeding suppression via the modulation of NPY gene expression.
INTRODUCTION
9 above except the changes of two steps (annealing and cycles) that were described as follows: PKA (60ዊ, 28 cycles); CREB (60ዊ, 35 cycles); CART (60ዊ, 28 cycles ); GAPDH (52ዊ, 25 cycles). The sequences of primers used in RT-PCR were shown in Table 1 .
Western Blotting
Protein samples extracted from hypothalamus tissue were separated in a 12.5% 
Gel Electrophoresis
At the completion of RT-PCR, 8 µl of each PCR product was subsequently Page 9 of 45 separated by flat-bed gel electrophoresis on a 3% agarose gel. Gels stained by ethidium bromide (0.5 µg/ml, Sigma-Aldrich Co., MO, USA) were visualized under UV light, photographed, and then scanned densitometrically. Ratios of NPY and GAPDH mRNA were calculated to determine relative NPY mRNA levels. Contents of NPY mRNA in AMPH-treated group were indicated as the percentage of control group. The ratio of NPY/GAPDH mRNA was measured by digital densitometry (Hoefer, San Francisco, CA, USA). Similar steps were used to determine the contents of PKA, CREB and CART mRNA.
Lateral Ventricular Cannulation
A stereotaxic surgery (Kopf Model 900, Tujunga, CA, USA) of rat was performed under anesthesia with pentobarbital (30 mg/kg, IP). The target of cannulation was close to the junction between the right lateral ventricle and the third ventricle (coordinates: 0.8 mm posterior to Bregma, 1.5 mm from the midline, and 3.5~4.0 mm below the dura) (43). A 23-g stainless steel guide cannula was implanted and secured to the skull using stainless-steel screws and dental cement. A correct placement was confirmed by observing a transient and rapid inflow of vehicle in PE tube connected with a 28-g injector cannula. The cannula was then occluded with a 28-g stylet. For ICV infusion of PKA or CREB antisense, the stylet was replaced with a 28-g injector Page 10 of 45 cannula extending 0.5 mm below the tip of guide cannula. Behavioral testing began at 1 week after the surgery. For all experiments verification of cannula placement was done by the administration of angiotensin II (100 ng/rat; Sigma-Aldrich, USA).
Angiotensin II reliably induced water drinking in non-deprived rats when administered into the ventricles (44). Only data from rats drinking more than 10 ml within 30 min were included in this study.
ICV Administration of Antisense ODN
To determine the effect of PKA or CREB antisense on the anorectic response of AMPH, rats (n=6-8 for each group) were given with antisense (20 µg in a 10ዊµl vehicle; ICV) at 1 h before AMPH (4 mg/kg; IP) daily for 4 days. Before AMPH treatment, rats were ICV injected with similar dose of antisense daily for 2-3 days until the response of feeding behavior was slightly reduced. This is due to the fact that either continuous or repeated ICV injections of antisense may be necessary to maximize behavioral effect and especially to block the synthesis of constitutively active gene product (41, 64). The sequences of the CREB antisense ODN and missense ODN were 5'-TGGTCATCTAGTCACCGGTG-3' and 5'-GTCTGCAGTCGATCTACGGT-3', respectively. As expected, the CREB antisense sequence showed a perfect match (as the reverse complement) with the rat CREB Another control experiment was designed to determine the effect of PKA or CREB antisense S-ODN pretreatment on NPY mRNA level in AMPH-treated rats.
Rats (n=6-8 each group) were injected daily with antisense or missense (20 µg in a 10ዊµl vehicle; ICV) at 1 h before daily AMPH (4 mg/kg; IP) for 2 days (Day 0 and antisense daily for 2-3 days until the response of feeding behavior was slightly reduced. At 40 min after AMPH treatment, the hypothalamus was removed to determine the NPY mRNA content.
To determine the efficiency of PKA or CREB antisense, rats (n=4-6 each group)
were injected daily with antisense or missense (20 µg in a 10ዊµl vehicle; ICV) for 2-3 days until the response of feeding behavior was slightly reduced in antisense group.
At 40 min after the last treatment of antisense or missense, the hypothalamus was removed to determine the PKA or CREB mRNA content.
Statistical Analysis
Data were presented as the mean ± SEM. T-test, two-way or one-way ANOVA followed by Dunnett's test was used to detect significances of difference among groups. P<0.05 was considered to be statistically significant.
RESULTS

The Effect of AMPH on Feeding Behavior
Statistical analysis (two-way ANOVA) revealed significant dose-dependent This result suggested that daily AMPH (2 mg/kg) produced a marked anorectic response on Day1 and a return to normal intake on the following days, but daily AMPH (4 mg/kg) produced a continuous anorectic response during a 4-day period of time. Therefore, the 2 mg/kg AMPH dose was employed for subsequent measures.
Effects of AMPH on NPY, PKA, CREB and CART mRNA Levels
Results shown in Figure 2 revealed that daily AMPH decreased NPY mRNA level but increased PKA, CREB and CART mRNA levels during a 4-day period.
Analysis with one-way ANOVA revealed a decrease of NPY mRNA contents 
Effects of AMPH on NPY, PK and CREB Protein Levels
AMPH could decrease hypothalamic NPY contents that were markedly decreased on Day 1 with a gradual return to normal level on the followings during a 4-day period in AMPH-treated rats as described in our previous report (27). This change of NPY contents following AMPH treatment was in a manner consistent with the alteration of NPY mRNA levels shown in the present study. Results shown in Comparing the food intake between antisense/AMPH-treated and AMPH-treated groups in every day, significant effects were seen in all four days. These results indicate that CREB knock down could block the anorectic response of AMPH.
No statistical significance was obtained in 2 mg/kg AMPH-treated rats receiving missense/CSF (vehicle) injection (shown in Fig. 3 ) or not (shown in Fig. 1 ) (t-test),
indicating the noninterference of missense treatment and vehicle on AMPH's action.
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Similar comparisons could be observed in our previous report (30).
The Effect of PKA or CREB Antisense on NPY mRNA Levels
Results shown in Figure 5 revealed that PKA or CREB antisense reversed partially or completely the decreased level of NPY mRNA in AMPH-treated rats.
Using GAPDH as the internal standard, the ratio of NPY/GAPDH mRNA in each 
Effects of Antisense S-ODN on PKA or CREB mRNA Level
Results shown in Figure 6 revealed that ICV injection of PKA or CREB antisense S-ODN in rats resulted in a significant decrease of PKA or CREB mRNA level. Using GAPDH as the internal standard, the ratio of PKA or CREB mRNA over GAPDH mRNA in each group was calculated and compared. Results from statistical analysis revealed that PKA or CREB mRNA content was decreased in antisense-treated rats as compared with the missense-treated group (t-test, P<0.05).
These results revealed that ICV injection of PKA or CREB antisense was effective to reduce the hypothalamic PKA or CREB mRNA level in rats. Moreover, CREB and PKA antisenses used in this study are sequence specific since they didn't interfere with each other.
DISCUSSION
NPY has been reported to involve the anorectic action of AMPH. However, molecular mechanisms underlying this action are not well known. In this study, we found that the alteration in NPY mRNA content following daily AMPH treatment was consistent with the change of feeding behavior, confirming the involvement of NPY gene in AMPH anorexia and suggesting that AMPH tolerance was related to the expression. This result supported that activations of PKA and CREB signaling were involved in the inhibition of NPY gene expression in AMPH-treated rats.
Similar result could be observed in a previous report (8) although the injected site and the method for detecting CREB were different. Using a similar sequence of CREB antisense S-ODN injected directly into the perifornical hypothalamic area, Chance et al found that both NPY-stimulated feeding and ad lib feeding were reduced.
Both reductions were accompanied with a decrease in CREB protein (vs. a decrease in CREB mRNA level in the present study). These results revealed that CREB protein was involved in NPY-mediated feeding and that perifornical area might be one of the sites on which antisense exerted its effect. 
